#1 Attorneys Network
<span class="articleLocation”>Drugstore chain CVS Health Corp has cut
the price of a generic version of Impax Laboratories Inc’s emergency allergy injection, a device similar to Mylan
NV’s controversial EpiPen.
Mylan, which has been lambasted by consumers and lawmakers
for raising EpiPen prices six-fold in less than a decade, said
last month it would start selling a generic version of EpiPen
for $300 per two-pack, a more than 50 percent discount.
CVS’s move comes after health insurer Cigna Corp revised its coverage list to include the generic version of
Epipen instead of the branded version.
“These formulary changes were anticipated and are why we
anticipate successful generic utilization,” Mylan spokeswoman
Julie Knell said in an email.
Impax’s branded Adrenaclick has not caught on with patients
and doctors and is not considered by regulators to be an exact
copy of EpiPen.
The authorized Adrenaclick generic, which was earlier sold
at about $200 a two-pack, is now available at all CVS Pharmacy
locations at $109.99 for both insured and cash-paying patients
without insurance, CVS said on Thursday.
The two-pack device, which is assembled by hand by
manufacturers, has a list price of more than $400.
Mylan’s branded EpiPen doublet has a list price of $649.99,
and the authorized generic costs $339.99, CVS added.
#1 Attorneys Search Engine